Vaccinia Antibodies

Santa Cruz Biotechnology offers a broad range of Vaccinia Antibodies for various research applications. Vaccinia Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vaccinia virus, a member of the Poxviridae family, is historically significant as the virus used in the smallpox vaccine. Understanding the mechanisms of Vaccinia virus can provide insights into viral pathogenesis and host immune responses. Research focused on Vaccinia virus continues to advance knowledge in viral immunology and vaccine development. Vaccinia virus research has contributed significantly to understanding viral replication, immune evasion strategies, and host-pathogen interactions. Modern investigations of Vaccinia virus mechanisms have revealed new possibilities for therapeutic applications. Ongoing studies of Vaccinia proteins enhance our understanding of viral entry, replication, and assembly processes. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific discoveries in virology and immunology.